Amiodarone Injection Solution and Sodium Polystyrene Sulfonate Powder
Determining the interaction of Amiodarone Injection Solution and Sodium Polystyrene Sulfonate Powder and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Talk to your doctor before using amiodarone together with sodium polystyrene sulfonate. Combining these medications can increase the risk of an irregular heart rhythm that may be serious. If your doctor prescribes these medications together, you may need regular monitoring of your electrolyte (magnesium, potassium) levels as well as other tests to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with amiodarone. In addition, you should let your doctor know if you experience signs of electrolyte disturbance such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: Amiodarone can cause dose-related prolongation of the QT interval. Theoretically, coadministration with agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins, stimulant laxatives) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsades de pointes, because of additive arrhythmogenic potential.
MANAGEMENT: Coadministration of amiodarone with medications that can cause potassium and/or magnesium disturbances should generally be avoided. Serum electrolytes should be evaluated and any abnormalities corrected prior to initiating therapy with amiodarone. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsades de pointes such as dizziness, palpitations, or syncope.
- Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5
- "Product Information. Amiodarone Hydrochloride (amiodarone)." Bedford Laboratories, Bedford, OH.
Generic Name: amiodarone
Brand name: Pacerone, Cordarone, Nexterone
Synonyms: Amiodarone
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amiodarone Injection Solution-Sodium polystyrene sulfonate Rectal
- Amiodarone Injection Solution-Sodium Polystyrene Sulfonate Suspension
- Amiodarone Injection Solution-Sodium Sulf/Potassium Sulf/Mag Sulf/Polyethylene Glycol-Electrolyte Soln
- Amiodarone Injection Solution-Sodium Sulfacetamide and Sulfur Aqueous Gel
- Amiodarone Injection Solution-Sodium Sulfacetamide and Sulfur Cleanser
- Amiodarone Injection Solution-Sodium Sulfacetamide and Sulfur Cream
- Sodium Polystyrene Sulfonate Powder-Amiodarone Intravenous
- Sodium Polystyrene Sulfonate Powder-Amiodarone Intravenous, Oral
- Sodium Polystyrene Sulfonate Powder-Amiodarone Tablets
- Sodium Polystyrene Sulfonate Powder-Amitiza
- Sodium Polystyrene Sulfonate Powder-Amitriptyline
- Sodium Polystyrene Sulfonate Powder-Amitriptyline and chlordiazepoxide